SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.050-3.9%2:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote (312)3/23/1999 9:02:00 PM
From: Scott Ozer  Read Replies (1) of 441
 
I think the market sees what it wants to see, and down 1 pt is not good in my book. Without the share repurchase the erns would have been less than .10, so I see nothing to crow about. sales were up but it did not go to the bottom line. Net income was down, I guess the next research reports will tell us the view from the analysts point, This is a growth company, bigger sales and earnings is what it takes to get the attention of wall street--I dont see it screaming to be bought here right now. I think theyhave a great product list, but prhaps radiation of food is making in roads or the the company is not selling the products enough especially with ALL the food recalls YOU point out. The story is great, just get the word out without having to look for the obscure gains and reading the foot notes, etc, etc. Is the company in there buying stock, or the insiders at these bargin prices? As for next years earnings---lets see this years growth.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext